Geode Capital Management, LLC Vyant Bio, Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$0.62 - $1.37 $3,586 - $7,924
5,784 Added 3.06%
194,586 $177,000
Q3 2021

Nov 12, 2021
BUY
$2.26 - $3.74 $27,395 - $45,336
12,122 Added 6.86%
188,802 $439,000
Q2 2021

Aug 13, 2021
BUY
$2.88 - $4.81 $340,920 - $569,383
118,375 Added 203.03%
176,680 $660,000
Q1 2021

May 12, 2021
BUY
$2.89 - $8.6 $168,501 - $501,423
58,305 New
58,305 $270,000

Others Institutions Holding VYNT

# of Institutions
2
Shares Held
213K
Call Options Held
0
Put Options Held
0
View Full List

About Vyant Bio, Inc.

VYNT Quotes by TradingView
  • Ticker VYNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,343,200
  • Description
  • Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule c...
More about VYNT
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email